• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依维莫司诱发了一名结节性硬化症患者的机化性肺炎。

Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex.

作者信息

Lanfranco Julio, Holt Andrew, Montague Allison, Oza Twisha H, Elballat Mohammad, Romero-Legro Ivan H

机构信息

University of Tennessee Health Science Center, USA.

出版信息

Respir Med Case Rep. 2021 Jan 24;32:101347. doi: 10.1016/j.rmcr.2021.101347. eCollection 2021.

DOI:10.1016/j.rmcr.2021.101347
PMID:33598397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7868714/
Abstract

Organizing pneumonia is characterized by a distinct histologic pattern in the lung interstitium and presents clinically as hypoxemia, fever, cough, and dyspnea that is not attributable to concurrent infection. Typical etiologies of this condition include inflammatory disease, malignancy, toxic inhalation, and an array of medications including the mTOR inhibitor everolimus. In this report, we describe the case of a female with tuberous sclerosis complex on everolimus therapy for renal angiomyolipomas who presented to the hospital with persistent cough, dyspnea, and fevers and bilateral lower lobe opacities on chest X-ray despite multiple courses of antibiotic therapy. Bronchoscopy was performed with transbronchial biopsies, and results demonstrated a lymphocytic predominance and pathologic findings of intraluminal plugs composed of fibroblasts and myofibroblasts consistent with organizing pneumonia. Everolimus therapy was discontinued and patient completed a steroid course with resolution of symptoms. To our knowledge, this is the first published case of organizing pneumonia secondary to everolimus in a patient with tuberous sclerosis complex.

摘要

机化性肺炎的特征是肺间质出现独特的组织学模式,临床上表现为低氧血症、发热、咳嗽和呼吸困难,且这些症状并非由并发感染引起。该病症的典型病因包括炎症性疾病、恶性肿瘤、有毒气体吸入以及一系列药物,其中包括mTOR抑制剂依维莫司。在本报告中,我们描述了一名患有结节性硬化症复合体的女性病例,该患者因肾血管平滑肌脂肪瘤接受依维莫司治疗,尽管接受了多疗程抗生素治疗,但仍因持续咳嗽、呼吸困难和发热到医院就诊,胸部X光显示双侧下叶有模糊影。进行了支气管镜检查并取了经支气管活检,结果显示以淋巴细胞为主,且病理结果显示管腔内有由成纤维细胞和肌成纤维细胞组成的栓子,符合机化性肺炎。停用了依维莫司治疗,患者完成了一个疗程的类固醇治疗,症状得以缓解。据我们所知,这是首例发表的结节性硬化症复合体患者继发于依维莫司的机化性肺炎病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/0ff69606db94/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/521dd4e1b1ed/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/bb8387f6dca1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/2ca26ed90e19/gr3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/d4225161a813/gr3b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/02bf4743319e/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/82b04301a23f/gr4b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/8df4624d3ad3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/0ff69606db94/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/521dd4e1b1ed/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/bb8387f6dca1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/2ca26ed90e19/gr3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/d4225161a813/gr3b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/02bf4743319e/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/82b04301a23f/gr4b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/8df4624d3ad3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/874c/7868714/0ff69606db94/gr6.jpg

相似文献

1
Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex.依维莫司诱发了一名结节性硬化症患者的机化性肺炎。
Respir Med Case Rep. 2021 Jan 24;32:101347. doi: 10.1016/j.rmcr.2021.101347. eCollection 2021.
2
A mechanistic target of rapamycin inhibitor, everolimus safely ameliorated lupus nephritis in a patient complicated with tuberous sclerosis.一种雷帕霉素作用机制靶点抑制剂依维莫司,安全改善了一名合并结节性硬化症患者的狼疮性肾炎。
Mod Rheumatol Case Rep. 2023 Jan 3;7(1):47-51. doi: 10.1093/mrcr/rxac033.
3
Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex.在三名新生儿中使用mTOR抑制剂依维莫司治疗与结节性硬化症相关的肿瘤。
Pediatr Neurol. 2015 Apr;52(4):450-3. doi: 10.1016/j.pediatrneurol.2015.01.004. Epub 2015 Jan 14.
4
Bilateral symmetrical upper-lobe opacities: an unusual presentation of bronchiolitis obliterans organizing pneumonia.双侧对称性上叶混浊:闭塞性细支气管炎伴机化性肺炎的一种不寻常表现。
Chest. 2000 Sep;118(3):863-5. doi: 10.1378/chest.118.3.863.
5
Long-Term Everolimus Treatment in Individuals With Tuberous Sclerosis Complex: A Review of the Current Literature.结节性硬化症患者的长期依维莫司治疗:当前文献综述
Pediatr Neurol. 2015 Jul;53(1):23-30. doi: 10.1016/j.pediatrneurol.2014.10.024. Epub 2014 Nov 8.
6
Severe pneumonia by Mycoplasma as an adverse event of everolimus therapy in patients with tuberous sclerosis complex.严重支原体肺炎作为结节性硬化症患者依维莫司治疗的不良事件。
Eur J Paediatr Neurol. 2016 Sep;20(5):758-60. doi: 10.1016/j.ejpn.2016.05.002. Epub 2016 May 14.
7
Cryptogenic organizing pneumonia associated with pregnancy: A case report.妊娠相关性隐源性机化性肺炎:一例报告
World J Clin Cases. 2022 Feb 26;10(6):1946-1951. doi: 10.12998/wjcc.v10.i6.1946.
8
Bronchiolitis obliterans-organizing pneumonia: an Italian experience.闭塞性细支气管炎伴机化性肺炎:意大利的经验。
Respir Med. 2000 Jul;94(7):702-8. doi: 10.1053/rmed.2000.0805.
9
Fatal case of cryptogenic organizing pneumonia associated with everolimus.与依维莫司相关的隐源性机化性肺炎致死病例。
Ann Saudi Med. 2014 Sep-Oct;34(5):437-9. doi: 10.5144/0256-4947.2014.437.
10
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.依维莫司治疗结节性硬化症相关室管膜下巨细胞星形细胞瘤的疗效和安全性(EXIST-1):一项多中心、随机、安慰剂对照的 3 期临床试验。
Lancet. 2013 Jan 12;381(9861):125-32. doi: 10.1016/S0140-6736(12)61134-9. Epub 2012 Nov 14.

本文引用的文献

1
Drug-Related Pneumonitis During Mammalian Target of Rapamycin Inhibitor Therapy: Radiographic Pattern-Based Approach in Waldenström Macroglobulinemia as a Paradigm.雷帕霉素哺乳动物靶点抑制剂治疗期间的药物相关性肺炎:以华氏巨球蛋白血症为例基于影像学模式的方法
Oncologist. 2015 Sep;20(9):1077-83. doi: 10.1634/theoncologist.2015-0033. Epub 2015 Jul 23.
2
Organizing pneumonia: chest HRCT findings.机化性肺炎:胸部高分辨率CT表现
J Bras Pneumol. 2015 May-Jun;41(3):231-7. doi: 10.1590/S1806-37132015000004544.
3
Fatal case of cryptogenic organizing pneumonia associated with everolimus.
与依维莫司相关的隐源性机化性肺炎致死病例。
Ann Saudi Med. 2014 Sep-Oct;34(5):437-9. doi: 10.5144/0256-4947.2014.437.
4
Interstitial pneumonitis caused by everolimus: a case-cohort study in renal transplant recipients.依维莫司相关性间质性肺炎:肾移植受者的病例队列研究。
Transpl Int. 2014 May;27(5):428-36. doi: 10.1111/tri.12275. Epub 2014 Mar 5.
5
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.依维莫司治疗结节性硬化症相关的血管平滑肌脂肪瘤或散发性淋巴管平滑肌瘤病(EXIST-2):一项多中心、随机、双盲、安慰剂对照试验。
Lancet. 2013 Mar 9;381(9869):817-24. doi: 10.1016/S0140-6736(12)61767-X.
6
Two cases of everolimus-associated interstitial pneumonia in patients with renal cell carcinoma.
Intern Med. 2011;50(24):3013-7. doi: 10.2169/internalmedicine.50.6133. Epub 2011 Dec 15.
7
Everolimus-related organizing pneumonia: a report establishing causality.
Invest New Drugs. 2012 Jun;30(3):1244-7. doi: 10.1007/s10637-010-9624-y. Epub 2010 Dec 29.
8
Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma.晚期肾细胞癌依维莫司治疗后的非传染性肺炎。
Am J Respir Crit Care Med. 2010 Aug 1;182(3):396-403. doi: 10.1164/rccm.200911-1720OC. Epub 2010 Mar 1.
9
Severe everolimus-associated pneumonitis in a renal transplant recipient.肾移植受者中与依维莫司相关的严重肺炎
Nephrol Dial Transplant. 2008 Oct;23(10):3353-5. doi: 10.1093/ndt/gfn401. Epub 2008 Jul 25.
10
Cryptogenic organising pneumonia.隐源性机化性肺炎
Eur Respir J. 2006 Aug;28(2):422-46. doi: 10.1183/09031936.06.00013505.